Acoustic neuroma, also known as vestibular schwannoma, is a non-cancerous (benign) tumor that develops on the balance and hearing nerve (cranial nerve) between the inner ear and brain. Symptoms of acoustic neuroma include hearing impairment, tinnitus, dizziness and imbalance. A majority of acoustic neuromas are surgically removed to relieve pressure and limit tumor growth. The global acoustic neuroma market is primarily driven by the growing geriatric population which is susceptible to develop acoustic neuromas.
The acoustic neuroma market is estimated to be valued at USD 2.29 Bn in 2024 and is expected to reach USD 4.2 Bn by 2031, growing at a compound annual growth rate (CAGR) of 9% from 2024 to 2031.
Key players operating in the acoustic neuroma market are F. Hoffmann-La Roche Ltd., Siemens Healthcare Private Limited, GE Healthcare, GlaxoSmithKline plc, Novartis International AG
The rising awareness regarding early disease diagnosis and availability of minimally invasive treatment procedures such as stereotactic radiosurgery and microsurgery presents significant growth opportunities in the global Acoustic Neuroma Market.
The market is witnessing expansion in emerging countries of Asia Pacific, Latin America, and Middle East & Africa due to increasing healthcare expenditure and penetration of key market players in these regions.
Market drivers
The high prevalence of brain cancer coupled with growing geriatric population which is susceptible to brain cancer are the major market drivers. It is estimated that around 33,000 new cases of brain cancer are diagnosed annually in the US alone. The rising healthcare expenditure per capita especially in developing countries will also aid the market growth over the forecast period.
PEST Analysis
Political: The healthcare policies and regulations introduced by governments will impact the acoustic neuroma market. Regulations surrounding device approval processes and reimbursement schemes determine the growth opportunities.
Economic: The economic conditions of regions and nations determine the spending capabilities of consumers and profits of organizations. Favorable economic growth increases resource allocation to the healthcare domain.
Social: Awareness among people about acoustic neuroma symptoms and available treatment options is growing. Social media is effectively spreading information. Changing lifestyle is also increasing disease incidence rates.
Technological: Advancements in imaging and surgical technologies are improving acoustic neuroma diagnosis and management. Robot-assisted surgeries and new drug candidates are currently under research and development. Virtual reality based solutions are also being explored.
Geographical Market Concentration
The acoustic neuroma market in terms of value is largely concentrated in developed regions like North America and Western Europe. This can be attributed to factors like availability of advanced healthcare infrastructure, high acceptance of advanced treatment techniques, and favorable reimbursement policies in these areas.
Fastest Growing Region
The Asia Pacific region is expected to witness the highest growth in the acoustic neuroma market during the forecast period. This growth can be credited to elements like rising healthcare expenditures, increasing medical tourism, growing awareness about disorders, and rapid economic development in emerging nations of the region.
Get this Report in Japanese Language: 聴神経腫瘍市場
Get this Report in Korean Language: 음향신경종 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
